Antituberculosis IgG antibodies as a marker of active Mycobacterium tuberculosis disease

Clinical and Vaccine Immunology

Volumn 19, Issue 4, 2012, Pages 522-526

  Welch, Ryan J ^a   Lawless, Kathleen M ^b   Litwin, Christine M ^a,c  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY HEALTH SYSTEM   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MYCOBACTERIUM ANTIGEN;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; FALSE POSITIVE RESULT; FEMALE; HUMAN; INFANT; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; UTAH; YOUNG ADULT;

EID: 84859372633     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05573-11     Document Type: Article

References (25)

1. Abebe F, Bjune G. 2009. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin. Exp. Immunol. 157:235-243.
2. Anderson BL, Welch RJ, Litwin CM. 2008. Assessment of three commercially available serologic assays for detection of antibodies to Mycobacterium tuberculosis and identification of active tuberculosis. Clin. Vaccine Immunol. 15:1644-1649.
3. Azzurri A, et al. 2006. Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea. Int. J. Immunopathol. Pharmacol. 19:199-208.
4. Demkow U, et al. 2007. Heterogeneity of antibody response to myobacterial antigens in different clinical manifestations of pulmonary tuberculosis. J. Physiol. Pharmacol. 58(Suppl. 5):117-127. (Pubitemid 351346660)
5. Duchini A, Goss JA, Karpen S, Pockros PJ. 2003. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin. Microbiol. Rev. 16:357-364. (Pubitemid 36871311)
6. Frieden TR. 2002. Can tuberculosis be controlled? Int. J. Epidemiol. 31: 894-899. (Pubitemid 35446858)
7. Glatman-Freedman A, Casadevall A. 1998. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin. Microbiol. Rev. 11:514 -532.
8. Goldfarb NS, et al. 2001. Hypogammaglobulinemia in lung transplant recipients. Transplantation 71:242-246. (Pubitemid 32126107)
9. Greenaway C, et al. 2005. Humoral response to Mycobacterium tuberculosis antigens in patients with tuberculosis in the Gambia. Int. J. Tuberc. Lung Dis. 9:1112-1119. (Pubitemid 41435093)
10. Gruver AL, Hudson LL, Sempowski GD. 2007. Immunosenescence of ageing. J. Pathol. 211:144-156. (Pubitemid 46195513)
11. Gupta S, Shende N, Bhatia AS, Kumar S, Harinath BC. 2005. IgG subclass antibody response to mycobacterial serine protease at different stages of pulmonary tuberculosis. Med. Sci. Monit. 11:CR585-CR588. (Pubitemid 43138424)
12. Hendrickson RC, et al. 2000. Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis. J. Clin. Microbiol. 38:2354-2361. (Pubitemid 30414364)
13. Hoff ST, et al. 2007. Evaluation of Mycobacterium tuberculosis-specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark. Clin. Infect. Dis. 45:575-582. (Pubitemid 47328637)
14. Levinson SS, Miller JJ. 2002. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin. Chim. Acta 325:1-15. (Pubitemid 35279621)
15. Lyashchenko K, et al. 1998. Heterogeneous antibody responses in tuberculosis. Infect. Immun. 66:3936-3940. (Pubitemid 28347858)
16. Mizusawa M, et al. 2008. Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis. Clin. Vaccine Immunol. 15:544-548. (Pubitemid 351967079)
17. Ongradi J, Stercz B, Kovesdi V, Vertes L. 2009. Immunosenescence and vaccination of the elderly, I. Age-related immune impairment. Acta Microbiol. Immunol. Hung. 56:199-210.
18. Pollock CA, et al. 1989. Immunoglobulin abnormalities in renal transplant recipients. Transplantation 47:952-956. (Pubitemid 19161827)
19. Samanich KM, et al. 2000. Serodiagnostic potential of culture filtrate antigens of Mycobacterium tuberculosis. Clin. Diagn. Lab. Immunol. 7:662-668. (Pubitemid 30463230)
20. Silva VM, Kanaujia G, Gennaro ML, Menzies D. 2003. Factors associated with humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of tuberculosis. Int. J. Tuberc. Lung Dis. 7:478-484. (Pubitemid 36565419)
21. Steingart KR, et al. 2009. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin. Vaccine Immunol. 16:260-276.
22. Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B. 2008. Biology of immune responses to vaccines in elderly persons. Clin. Infect. Dis. 46:1078-1084. (Pubitemid 351589876)
23. Weksler ME, Szabo P. 2000. The effect of age on the B-cell repertoire. J. Clin. Immunol. 20:240-249. (Pubitemid 30619395)
24. WHO. 2011. Commercial serodiagnostic tests for diagnosis of tuberculosis: policy statement. World Health Organization, Geneva, Switzerland.
25. WHO. 2010. Global tuberculosis control. World Health Organization, Geneva, Switzerland.